Copper
SupplementThe low divergence results from both the medical literature and community experience classifying copper as an effective agent in the presence of existing deficiency [s8, s9, c1, c2], while both sources consider the benefit of supplementation without confirmed deficiency to be unproven or risky [s4, s1, c3].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Copper is an essential trace mineral that most people get sufficiently through diet — supplementing without a documented deficiency is unnecessary and carries real risks at higher doses, including hepatotoxicity and pro-oxidative effects. The one well-justified use case is preventing zinc-induced copper depletion when taking high-dose zinc (>25 mg/day). The EFSA upper limit is 5 mg/day; Germany's BfR recommends no more than 1 mg per daily serving in supplements. Copper is absolutely contraindicated in Wilson's disease.
Description
Essential trace element for enzyme functions, collagen synthesis, iron metabolism, and immune function; deficiency can lead to anemia and neuropathy [s4, s5].
Copper is an essential trace element that the human body cannot synthesize itself and must therefore obtain through diet. In very small amounts (approx. 1–1.5 mg/day), it is indispensable for numerous physiological processes [s1]. As a cofactor for more than twenty copper-dependent enzymes, copper is involved in mitochondrial energy production (cytochrome c oxidase), antioxidant defense (superoxide dismutase 1, SOD1), collagen and elastin maturation (lysyl oxidase), iron metabolism (ceruloplasmin), and melanin synthesis (tyrosinase) [s5, s6, s7]. According to current surveys, the German population is adequately supplied with copper; true deficiency occurs primarily in individuals with malabsorption syndromes (e.g., following bariatric surgery, Crohn's disease), excessive zinc intake, or prolonged parenteral nutrition [s8, s9, s10]. Copper dietary supplements are used mainly to counteract copper depletion induced by high zinc doses (zinc inhibits copper absorption via induction of metallothionein) [s9]. Additionally, supplements are used for substitution in diagnosed copper deficiency [s8]. Available forms include copper gluconate, copper sulfate, copper bisglycinate (chelate), and copper citrate. According to the NIH, no clinical studies to date have directly compared the bioavailability of these forms in humans [s4]. Inorganic forms such as copper oxide are considered less bioavailable [s11]. Excessively high copper amounts are hepatotoxic; individuals with Wilson's disease (autosomal recessive copper metabolism disorder) must not take copper supplements [s12, s13].
Legal Status (DE)
In Germany, copper is marketable as an over-the-counter dietary supplement (NEM) in free commerce. It is subject to the LFGB and the Food Supplements Regulation (Directive 2002/46/EC). The BfR recommends a maximum amount of 1 mg Cu per recommended daily dose in supplements for adults; additional copper intake via supplements is not recommended for children and adolescents. The EFSA has established a tolerable upper intake level (UL) of 5 mg Cu/day for adults [s1, s2, s3].
Mechanism of Action
Copper acts exclusively as a cofactor of copper-dependent metalloenzymes. The key biochemical mechanisms are: 1. Mitochondrial respiratory chain: Copper is an essential component of cytochrome c oxidase (Complex IV). Copper deficiency impairs ATP production and can lead to fatigue and weakness [s5, s7]. 2. Antioxidant defense: The copper/zinc-dependent superoxide dismutase 1 (Cu/Zn-SOD1) converts superoxide radicals into hydrogen peroxide and oxygen [s5]. 3. Iron metabolism: Ceruloplasmin — the primary copper-containing plasma protein — oxidizes Fe²⁺ to Fe³⁺ (ferroxidase activity), enabling iron to bind to transferrin and be transported. Copper deficiency therefore secondarily causes impaired iron utilization and anemia [s6]. 4. Collagen and elastin synthesis: The copper-dependent lysyl oxidase (LOX) covalently cross-links collagen and elastin molecules. Without sufficient copper, this cross-linking is absent, resulting in structural weaknesses in connective tissue, bone, and blood vessels [s14, s15]. 5. Neurotransmitter synthesis: Dopamine-β-hydroxylase converts dopamine to noradrenaline and is copper-dependent. Copper deficiency can thereby affect the noradrenergic system [s5]. 6. Immune function: Copper is involved in the proliferation and function of immune cells as well as neutrophil activity; copper deficiency is a recognized cause of neutropenia [s8, s9]. 7. Absorption and transport: In the small intestine, copper is absorbed primarily via the CTR1 transporter. In the blood, it is transported bound to ceruloplasmin (~95%) and albumin. Zinc induces metallothionein in enterocytes, which binds copper and thereby competitively inhibits its absorption [s9].
Dosing
Prävention zinkinduzierter Kupferdepletion
- Dose
- 1–2 mg elemental copper
- Frequency
- 1× täglich
- Route
- oral
- Duration
- Solange hohe Zinkdosen (>25 mg/Tag) eingenommen werden
- Timing
- Separated from zinc by time (min. 2 hours apart)
- With food
- empfohlen
Behandlung von Kupfermangel (oral)
- Dose
- 2–4 mg elemental copper
- Frequency
- 1–3× täglich (nach ärztlicher Anweisung)
- Route
- oral
- Duration
- Bis zur Normalisierung der Serumspiegel, danach Anpassung
- Timing
- With meals to improve tolerability
- With food
- empfohlen
Allgemeine Grundversorgung (nur bei dokumentiertem Mangel)
- Dose
- 1 mg elemental copper
- Frequency
- 1× täglich
- Route
- oral
- Duration
- Bedarfsabhängig, ärztliche Kontrolle empfohlen
- Timing
- Morning with meal
- With food
- empfohlen
The EFSA has established a tolerable upper intake level (UL) of 5 mg Cu/day for adults [s2]. The BfR recommends a maximum of 1 mg Cu per recommended daily dose in supplements [s1]. Gastrointestinal side effects have been observed at 10–15 mg/day [s13].
Supplementation without confirmed deficiency is not recommended by the BfR or consumer protection organizations, as dietary intake in Germany is generally sufficient [s1]. Copper should be taken separately from zinc.
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Übelkeit, Erbrechen, Magenbrennen (akut bei höheren Dosen) In clinical studies with various copper salts, nausea was described as the first adverse effect upon acute exposure. Heartburn and vomiting were observed at doses of 10–15 mg/day [s12, s13]. | häufig | leicht |
| Durchfall, gastrointestinale Störungen Diarrhea and vomiting have been observed following ingestion of 15–75 mg copper/day [s13]. | gelegentlich | leicht |
| Hepatotoxizität (Leberschäden) bei chronischer Überdosierung Chronically elevated copper intake can cause hepatic damage up to and including liver cirrhosis. Clinical manifestations range from gastrointestinal complaints to hepatic insufficiency [s12]. | selten | schwer |
| Prooxidativer Effekt: erhöhte Bildung freier Radikale bei hohen Kupferspiegeln Elevated copper levels can promote free radical formation and have been linked to neurological disorders and depression [s13]. | theoretisch | moderat |
| Kupfermangel durch Verdrängung bei überhöhter Zinkzufuhr (indirekte Wechselwirkung) Conversely, copper can displace zinc at very high supplementation levels, in turn causing zinc deficiency; this balance must be considered [s9, c1]. | gelegentlich | moderat |
Contraindications
In Wilson's disease, copper metabolism is genetically impaired; even normal copper amounts lead to accumulation in the liver, CNS, eyes, and kidneys with severe organ damage. Copper supplements are absolutely contraindicated [s12, s13].
The liver is the primary organ for biliary copper excretion. Impaired hepatic function may lead to copper accumulation [s12].
Individuals with genetic disorders of copper metabolism beyond Wilson's disease are at risk at significantly lower intake levels [s4].
The BfR recommends against giving copper dietary supplements to children and adolescents, as no safe upper limits have been defined and deficiency in this age group is unlikely [s1].
Increased requirements during pregnancy and lactation; however, supplementation should only be undertaken in confirmed deficiency and under medical supervision [s4].
Interactions
Synergistic
Alpha-lipoic acid can chelate copper ions and reduce their absorption or bioavailability. When taken simultaneously, copper supply may be diminished, so a time gap between both substances is recommended.
GHK-Cu is an endogenous tripeptide that transports copper(II) ions in non-toxic form into cells. The binding affinity of GHK to copper is comparable to that of albumin, enabling efficient copper delivery to tissue. Copper supplementation and GHK-Cu potentially complement each other in tissue copper supply.
High zinc doses (>25 mg daily) can cause copper deficiency, as both minerals compete for the same transporter (DMT-1). Concurrent intake of 1–2 mg copper is recommended when supplementing zinc above 25 mg daily to maintain copper status. The combination in a balanced ratio is therefore beneficial.
Caution
High iron doses can inhibit copper absorption in the small intestine and vice versa, as both metals compete for the same transporter (DMT-1). When taking iron and copper supplements simultaneously, bioavailability of both minerals may be reduced. A time gap of at least 2 hours is recommended.
Interactions between molybdenum ions and copper lead to mutually reduced absorption. When supplementing both trace elements simultaneously, copper bioavailability may significantly decrease. A time gap between doses is advisable at higher doses.
High zinc doses (>50 mg/day over several weeks) significantly inhibit copper absorption and can lead to clinical copper deficiency. Both trace elements compete for the divalent metal transporter DMT-1 in the small intestine. A time gap of at least 2 hours or concurrent supplementation of 1–2 mg copper is recommended.
Alpha-lipoic acid can mitigate copper-induced oxidative damage, which is beneficial at high copper doses. However, alpha-lipoic acid can also chelate free copper ions, reducing the bioavailability of copper supplements. Caution is advised with therapeutic copper supplementation.
High-dose vitamin C can affect copper absorption in the stomach by lowering gastric pH; simultaneously, ascorbate in the presence of free copper can promote pro-oxidative reactions (Fenton-like reaction). This effect is minimal at normal supplementation doses but relevant at very high vitamin C doses. A time gap with high-dose vitamin C intake is advisable.
Studies
Tier A — High Evidence
Outcome: Normalization of serum copper, ceruloplasmin, and hematological parameters in copper deficiency
Effect Size: Anemia and neutropenia responded rapidly to copper administration; neurological symptoms improved only partially [s17]
Outcome: Blood copper enzyme activities (SOD1, ceruloplasmin) and cardiovascular health parameters
Effect Size: Significant increase in copper enzyme activities with 3 mg/day Cu supplementation; no significant effect on cardiovascular markers [s16]
Tier B — Moderate Evidence
Outcome: Clinical course of copper deficiency myelopathy under oral supplementation
Effect Size: Progression of myelopathy ceased with copper administration; complete recovery was rare, improvements mostly partial [s8]
Outcome: Diagnosis, causes, and treatment approaches for acquired copper deficiency syndrome
Effect Size: Clear recommendation for supplementation in deficiency; evidence base for oral vs. IV administration limited [s10]
Tier C — Low Evidence
Outcome: Copper availability controls synthesis of mature elastin and collagen in aortic tissue
Effect Size: Copper depletion prevented complete collagen cross-linking; supplementation restored it [s14]
Community Evidence
Top reported benefits
- Improvement in energy and strength after correction of zinc-induced copper deficiency
- Normalization of hematological values (anemia, neutropenia)
- Improvement of neurological symptoms (paresthesia, weakness) in deficiency states
- Prevention of copper deficiency during concurrent high-dose zinc supplementation
Top reported issues
- Uncertainty about correct dosage and ratio to zinc
- Concern about pro-oxidative effects with oversupplementation
- No perceptible benefit in the absence of an existing deficiency
- Gastrointestinal intolerance at higher doses
Community forums frequently discuss the risk of copper accumulation with excessive supplementation, as well as the risk of lowering zinc levels through too much copper. Individual users warn of reports regarding possible tumor-promoting effects at very high copper levels — these concerns are overrepresented from a lay perspective; the clinical evidence in this regard relates primarily to Wilson's disease patients and animal models [c1, c2, c3].
Scientific Sources
- Effects of Copper Supplementation on Blood Lipid Level: a Systematic Review and a Meta-Analysis on Randomized Clinical Trials
Multiple authors (2020). Biological Trace Element ResearchBPMID:33030656 - Kupfer zur Nahrungsergänzung? – FAQ
Verbraucherzentrale Deutschland (2023). Verbraucherzentrale.deBLink - Copper Deficiency Myelopathy (Human Swayback)
Kumar N (2006). Mayo Clinic ProceedingsBLink - Copper Gluconate VS Copper Glycinate: Which Is Better?
Nutriavenue Editorial Team (2023). Nutriavenue.comCLink - Copper Toxicity – StatPearls
Gaetke LM, Chow-Johnson HS, Chow CK (2023). StatPearls, NCBI BookshelfBLink - Kupfer – Sicherheitsbewertung und Nebenwirkungen
Eucell Fachredaktion (2022). Eucell.de / VitalstofflexikonCLink - Copper and the synthesis of elastin and collagen
Rucker RB, Kosonen T, Clegg MS, et al. (1998). PubMed / Journal of NutritionCPMID:6110524 - Advances in copper-containing biomaterials for managing bone-related diseases
Zhang Y, Liu X, Chen S, et al. (2025). Regenerative BiomaterialsBDOI - A randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular health
DiSilvestro RA, Joseph E, Zhang W, et al. (2012). Metabolism: Clinical and ExperimentalAPMID:22444781 - What is the evidence supporting the use of intravenous copper for copper deficiency?
Drug Information Group, University of Illinois Chicago (2022). University of Illinois Chicago Drug Information GroupBLink - Kupfermangel – eine behandelbare Ursache der Myelopathie
Springermedizin Redaktion (2020). Springermedizin.deCLink - Risiken und Nutzen von Kupfer im Licht neuer Erkenntnisse zur Kupferhomöostase
Pohanka M (2013). ScienceDirect / Ernährungs UmschauBLink - Re-evaluation of the existing health-based guidance values for copper and exposure assessment from all sources
EFSA Scientific Committee (2023). EFSA JournalADOI - Aufnahme von Kupfer: In Spuren lebensnotwendig, in größeren Mengen riskant – FAQ
Bundesinstitut für Risikobewertung (BfR) (2023). BfRALink - Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women
["Bügel S","Harper A","Rock E","O'Connor JM","Bonham MP","Strain JJ"] (2005). British Journal of NutritionCPMID:16115357DOI - Alpha Lipoic Acid and Monoisoamyl-DMSA Combined Treatment Ameliorates Copper-Induced Neurobehavioral Deficits, Oxidative Stress, and Inflammation
["Patwa J","Thakur A","Flora SJS"] (2022). ToxicsCPMID:36422998DOI - Aktualisierte Höchstmengenvorschläge für Vitamine und Mineralstoffe in Nahrungsergänzungsmitteln und angereicherten Lebensmitteln 2024 – Stellungnahme 006/2024
Bundesinstitut für Risikobewertung (BfR) (2024). BfRALink - Copper – Health Professional Fact Sheet
National Institutes of Health, Office of Dietary Supplements (2023). NIH ODSBLink - Copper – Linus Pauling Institute Micronutrient Information Center
Linus Pauling Institute, Oregon State University (2022). Linus Pauling InstituteBLink - Biochemistry, Ceruloplasmin – StatPearls
Shim YS, Lee ES, Kim SH, et al. (2023). StatPearls, NCBI BookshelfBLink - Copper Metabolism – Overview
ScienceDirect Topics (2022). ScienceDirect TopicsBLink - Copper deficiency myelopathy – PMC Review
Jaiser SR, Winston GP (2010). Journal of NeurologyAPMID:19921117DOI - Copper deficiency anemia: review article
Fujita M, Ando K, Nagata S, et al. (2018). International Journal of HematologyBPMID:29959467
Community Sources
Storage
Unopened
Store dry at room temperature, protected from direct sunlight.
Opened
Keep container tightly closed; avoid moisture to prevent clumping.
Notes
Copper salts can oxidize upon contact with air and moisture. Do not store in metallic containers. Keep out of reach of children.